glutathione and triple negative breast cancer

glutathione and triple negative breast cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Metabolic interplay between exogenous cystine

Name: glutathione and triple negative breast cancer Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Metabolic interplay between exogenous cystine
Brand: equiscorp.hu
SKU: 17160727252
Price: 27.39 USD
Availability: InStock
Rating: 4.3528 (19 reviews)

Metabolic interplay between exogenous cystine and glutamine dependence in triple negative breast cancer Cell Death Discovery Full article: Glutathione and acid dual responsive nanomaterials loaded with methotrexate and magnolol for triple negative breast cancer treatment CD36 enhances sensitivity of triple negative breast cancer cells to palmitate induced ferroptosis Cell Death & Disease Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC

SKU: 17160727252 · From equiscorp.hu

4.4

USD27.39 USD59.39

Pay in 4 interest-free payments of $6.85 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Palmoplantar pustulosis (whose differential diagnosis can include dyshidrotic eczema, contact dermatitis, pityriasis rubra pilaris, acquired palmoplantar keratoderma, tinea pedis, and tinea manuum) was also found in 41% of these patients

Treatment with dexamethasone was found to significantly reduce TLR4 and MyD88 expression in monocytes derived from patients with tuberculous meningitis (TBM) (169)